Bellars Harris Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.48M Sell
87,774
-5,804
-6% -$367K 1.16% 42
2026
Q2
$5.39M Buy
+93,578
New +$5.37M 1.1% 44

Other funds holding BMY

Bellars Harris Wealth Management's BMY Position: Q3 2026 in Review

Bellars Harris Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 6.2% in Q3 2026, selling an estimated $367K and leaving 87,774 shares worth $5.48M. The position accounts for 1.16% of the portfolio, ranked #42.

Bellars Harris Wealth Management first reported a position in BMY in Q2 2026 and has held it in 2 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Bellars Harris Wealth Management held 87,774 shares of Bristol-Myers Squibb worth $5.48M as of Q3 2026.
  • Bellars Harris Wealth Management sold 5,804 Bristol-Myers Squibb shares in Q3 2026, an estimated $367K.
  • Bristol-Myers Squibb made up 1.16% of Bellars Harris Wealth Management's portfolio in Q3 2026, its #42 holding.
  • Bellars Harris Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2026 and has held it in 2 quarters since.
  • 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Bellars Harris Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.